Literature DB >> 16172947

Possible effect of subclinical inflammation on daily life in familial Mediterranean fever.

Z Birsin Ozçakar1, Fatoş Yalçinkaya, Selçuk Yüksel, Banu Acar, Derya Gökmen, Mesiha Ekim.   

Abstract

This study was performed to investigate the attack-free complaints of patients with familial Mediterranean fever (FMF) and the impact of colchicine on these symptoms and on subclinical inflammation. A questionnaire that includes information about the disease course and symptoms during the attack-free period was administered to the parents of 50 FMF patients. For evaluation of the attack-free period, questions were asked about four items concerning daily activities of the children-weakness, lack of appetite, sleep problems, and decreased activity. The respondents rated the items and the total score was taken as the sum of all of the specific items. The laboratory values were noted from the patients' files. During the attack-free period, patients with mild disease had higher total scores, higher weakness, and decreased activity scores than patients with moderate disease. When we compared the daily activity scores before and after colchicine therapy, a statistically significant increase was observed in the total scores and in all of the specific item scores. Also a significant decrease was seen in the erythrocyte sedimentation rate and white blood cell counts, and a significant increase was seen in the hemoglobin levels during the attack-free period after colchicine usage. Regression of inflammation together with improvement in daily activities were observed. FMF patients seem to have complaints during the attack-free period that may be related to subclinical inflammation. Moreover, colchicine besides preventing the FMF attacks and the dangerous complication of amyloidosis also seems to hinder the symptoms of the attack-free period in children with FMF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172947     DOI: 10.1007/s10067-005-1148-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Acute phase response and evolution of familial Mediterranean fever.

Authors:  M Tunca; G Kirkali; M Soytürk; S Akar; M B Pepys; P N Hawkins
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

Review 2.  Familial Mediterranean fever.

Authors:  E Ben-Chetrit; M Levy
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

3.  Familial Mediterranean fever in children: the expanded clinical profile.

Authors:  H A Majeed; M Rawashdeh; H el-Shanti; H Qubain; N Khuri-Bulos; H M Shahin
Journal:  QJM       Date:  1999-06

4.  A controlled trial of colchicine in preventing attacks of familial mediterranean fever.

Authors:  D Zemer; M Revach; M Pras; B Modan; S Schor; E Sohar; J Gafni
Journal:  N Engl J Med       Date:  1974-10-31       Impact factor: 91.245

5.  Colchicine for familial Mediterranean fever.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

Review 6.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

7.  Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years.

Authors:  E Ben-Chetrit; M Levy
Journal:  Semin Arthritis Rheum       Date:  1991-02       Impact factor: 5.532

8.  Acute phase response in familial Mediterranean fever.

Authors:  C Korkmaz; H Ozdogan; O Kasapçopur; H Yazici
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

9.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

10.  Colchicine treatment in children with familial Mediterranean fever.

Authors:  N Ozkaya; F Yalçinkaya
Journal:  Clin Rheumatol       Date:  2003-10       Impact factor: 2.980

View more
  13 in total

1.  Risk factors for subclinical inflammation in children with Familial Mediterranean fever.

Authors:  Meral Torun Bayram; Tufan Çankaya; Elçin Bora; Salih Kavukçu; Ayfer Ülgenalp; Alper Soylu; Mehmet Türkmen
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

2.  Fatigue in familial Mediterranean fever and its relations with other clinical parameters.

Authors:  Mehmet Tuncay Duruoz; Cagri Unal; Duygu Karali Bingul; Firat Ulutatar
Journal:  Rheumatol Int       Date:  2017-11-14       Impact factor: 2.631

3.  Higher Pentraxin-3 Levels are Associated With Inflammation in Familial Mediterranean Fever.

Authors:  Mesudiye Bulut; Mevlut Ceri; Selman Unverdi; Mustafa Altay; Mehmet Senes; Zafer Aydın Ecemis; Murat Duranay
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

Review 4.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

Review 5.  Vascular comorbidities in familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Fatoş Yalçınkaya
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

Review 6.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

7.  The effect of colchicine on physical growth in children with familial mediterranean fever.

Authors:  Z Birsin Ozçakar; Gülsüm Kadioğlu; Zeynep Siklar; Asli Kavaz; F Nur Aksanal; Merih Berberoğlu; Mesiha Ekim; Gönül Ocal; Fatoş Yalçinkaya
Journal:  Eur J Pediatr       Date:  2009-12-17       Impact factor: 3.183

8.  Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balcı; Eray Akay; Gokhan Tumgor; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

9.  Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever.

Authors:  Vildan Bostanci; Hulya Toker; Soner Senel; Omer Poyraz; Aysun Akpinar; Emine Pirim Görgün; Olcay Bakar
Journal:  Clin Oral Investig       Date:  2016-04-11       Impact factor: 3.573

10.  Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever.

Authors:  Ismail Sari; Oguzhan Karaoglu; Gercek Can; Servet Akar; Aytac Gulcu; Merih Birlik; Nurullah Akkoc; Mehmet Tunca; Yigit Goktay; Fatos Onen
Journal:  Clin Rheumatol       Date:  2007-01-23       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.